Ventricular fibrillation in coronary artery bypass graft operation. Ventricular fibrillation and flutter
Conditions
Interventions
Intervention 1: All the patients received a standard monitoring, arterial and central venous catheter insertion. Premedication was applied by administering midazolam (0.05 mg/kg) with fentanyl (10 mic
Treatment - Drugs
All the patients received a standard monitoring, arterial and central venous catheter insertion. Premedication was applied by administering midazolam (0.05 mg/kg) with fentanyl (10 microgram/kg) and f
Sponsors
Hormozgan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: ASA class 3-4, atherosclerosis vessel coronary-history with no previous cardiopulmonary resuscitation, patients with no medication of digoxin-amiodarone-lidocaine-magnesium Exclusion criteria: Concurrent other cardiac surgery, emergency surgery, allergy to drugs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ventricular fibrillation. Timepoint: 15 minute before operation till 24 hours after operation in ICU. Method of measurement: Electrocardiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Central venous pressure. Timepoint: 15 minutes after anesthesia induction and 15 minutes after starting cardiopulmonary bypass. Method of measurement: Central venous pressure transducer monitor.;Mean arterial pressure. Timepoint: 15 minutes after anesthesia induction and 15 minutes after starting cardiopulmonary bypass. Method of measurement: Invasive arterial blood pressure monitor.;Heart rate. Timepoint: 15 minutes after anesthesia induction and 15 minutes after starting cardiopulmonary bypass. Method of measurement: electrocardiography monitor.;Arterial blood gases (pH, arterial partial pressure of oxygen, arterial partial pressure of carbon dioxide, bicarbonate concentration). Timepoint: At phases of (base line, heart arrest, patient warming, and pump separation). Method of measurement: Arterial catheter blood sampling.;Plasma (Na-K) electrolytes. Timepoint: At phases of (base line, heart arrest, patient warming, and pump separation). Method of measurement: Arterial catheter blood sampling.;Blood plasma glucose. Timepoint: At phases of (base line, heart arrest, patient warming, and pump separation). Method of measurement: Arterial catheter blood sampling.;Complete blood count of plasma. Timepoint: At phases of (base line, heart arrest, patient warming, and pump separation). Method of measurement: Arterial catheter blood sampling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeid Kashani
Hormozgan University of Medical Sciences
Outcome results
None listed